Elisabet Warnhammar

540 total citations
10 papers, 424 citations indexed

About

Elisabet Warnhammar is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Elisabet Warnhammar has authored 10 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Elisabet Warnhammar's work include Radiopharmaceutical Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (2 papers). Elisabet Warnhammar is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (2 papers). Elisabet Warnhammar collaborates with scholars based in Sweden and Denmark. Elisabet Warnhammar's co-authors include Ragnar Hultborn, Sture Lindegren, Jörgen Elgqvist, Holger Jensen, ANNA WEIMARCK, Ingrida Verbiené, Corrine Hanson, Lars Jacobsson, Håkan Andersson and Stig Palm and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiation Research and Nuclear Medicine and Biology.

In The Last Decade

Elisabet Warnhammar

10 papers receiving 412 citations

Peers

Elisabet Warnhammar
Mario Federico Spain
Alberto Massocco Italy
Melissa M. Thrall United States
W. C. Wood United States
Luis Z. Blanco United States
Valérie Dubé Canada
Hiltje de Graaf Netherlands
Sophie McGrath United Kingdom
Ergin Bengisu Türkiye
Jeff Reid United States
Mario Federico Spain
Elisabet Warnhammar
Citations per year, relative to Elisabet Warnhammar Elisabet Warnhammar (= 1×) peers Mario Federico

Countries citing papers authored by Elisabet Warnhammar

Since Specialization
Citations

This map shows the geographic impact of Elisabet Warnhammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabet Warnhammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabet Warnhammar more than expected).

Fields of papers citing papers by Elisabet Warnhammar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabet Warnhammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabet Warnhammar. The network helps show where Elisabet Warnhammar may publish in the future.

Co-authorship network of co-authors of Elisabet Warnhammar

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabet Warnhammar. A scholar is included among the top collaborators of Elisabet Warnhammar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabet Warnhammar. Elisabet Warnhammar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hultborn, Ragnar, et al.. (2019). Radiosensitivity: Gender and Order of Administration of G-CSF, An Experimental Study in Mice. Radiation Research. 191(4). 335–335. 5 indexed citations
2.
Elgqvist, Jörgen, Håkan Andersson, Holger Jensen, et al.. (2009). Intraperitoneal Alpha-Radioimmunotherapy in Mice Using Different Specific Activities. Cancer Biotherapy and Radiopharmaceuticals. 24(4). 509–513. 12 indexed citations
3.
Elgqvist, Jörgen, Håkan Andersson, Holger Jensen, et al.. (2009). Repeated Intraperitoneal -Radioimmunotherapy of Ovarian Cancer in Mice. Journal of Oncology. 2010. 1–5. 22 indexed citations
4.
Elgqvist, Jörgen, Håkan Andersson, Peter Bernhardt, et al.. (2006). Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2. International Journal of Radiation Oncology*Biology*Physics. 66(4). 1228–1237. 28 indexed citations
5.
Elgqvist, Jörgen, Håkan Andersson, Tom Bäck, et al.. (2006). Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab′)2: therapeutic efficacy and myelotoxicity. Nuclear Medicine and Biology. 33(8). 1065–1072. 31 indexed citations
6.
Elgqvist, Jörgen, Håkan Andersson, Tom Bäck, et al.. (2006). Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.. PubMed. 47(8). 1342–50. 56 indexed citations
7.
Elgqvist, Jörgen, Peter Bernhardt, Ragnar Hultborn, et al.. (2005). Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.. PubMed. 46(3). 464–71. 43 indexed citations
8.
Elgqvist, Jörgen, Håkan Andersson, Tom Bäck, et al.. (2005). Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.. PubMed. 46(11). 1907–15. 65 indexed citations
9.
Lundgren-Eriksson, L., et al.. (2002). Radio-and chemotoxicity in mice during hypothermia.. PubMed. 21(5). 3269–74. 11 indexed citations
10.
Hultborn, Ragnar, et al.. (1998). Prevalence of Klinefelter's syndrome in male breast cancer patients.. PubMed. 17(6D). 4293–7. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mario Federico Breakdown of academic impact, for papers by Alberto Massocco Breakdown of academic impact, for papers by Melissa M. Thrall Breakdown of academic impact, for papers by W. C. Wood Breakdown of academic impact, for papers by Luis Z. Blanco Breakdown of academic impact, for papers by Valérie Dubé Breakdown of academic impact, for papers by Hiltje de Graaf Breakdown of academic impact, for papers by Sophie McGrath Breakdown of academic impact, for papers by Ergin Bengisu Breakdown of academic impact, for papers by Jeff Reid
Rankless by CCL
2026